Novel antibodies targeting immune regulatory checkpoints for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel antibodies targeting immune regulatory checkpoints for cancer therapy

Published:2013-07-23 Issue:2 Volume:76 Page:233-247
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Lee Chern Siang¹,Cragg Mark¹,Glennie Martin¹,Johnson Peter¹

Affiliation:

1. Cancer Sciences Unit; Faculty of Medicine; University of Southampton; Southampton General Hospital; Southampton; SO16 6YD; UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12164/fullpdf

Reference148 articles.

1. Biological and clinical implications of lymphocyte hybridomas - tumor-therapy with monoclonal-antibodies;Levy;Annu Rev Med,1983

2. Monoclonal antibodies - therapeutic and diagnostic uses in malignancy;Lowder;West J Med,1985

3. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy;Schroff;Cancer Res,1985

4. Human immune response to multiple injections of murine monoclonal IgG;Shawler;J Immunol,1985

5. Production of functional chimaeric mouse/human antibody;Boulianne;Nature,1984

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Aspects of Integrated Nonclinical Drug Development: Concepts, Strategies, and Potential Pitfalls;A Comprehensive Guide to Toxicology in Nonclinical Drug Development;2024

2. Immunomodulatory mAbs as Tools to Investigate on Cis-Interaction of PD-1/PD-L1 on Tumor Cells and to Set Up Methods for Early Screening of Safe and Potent Combinatorial Treatments;Cancers;2021-06-08

3. MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3;Cell Death Discovery;2021-06

4. Safety profile of drugs for advanced melanoma: A report based on 2008–2018 US Food and Drug Administration Data;British Journal of Clinical Pharmacology;2020-12-29

5. Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells;Cancers;2020-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3